Keo Capital AB (STU:7M7) Sloan Ratio %: -19.27% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:7M7 Keo Capital AB STU:7M7
35 GF Score
Price €0.72
GF Value €0.21
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Keo Capital AB Sloan Ratio %?

Keo Capital AB STU:7M7 -4.37% 35 Sloan Ratio % is -19.27% as of Jun. 2026. GuruFocus rates STU:7M7 with a GF Score™ of 35/100 and a GF Value™ of €0.21 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Keo Capital AB's Sloan Ratio for the quarter that ended in Jun. 2026 was -19.27%.

Warning Sign:

When sloan ratio (-47.24)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Jun. 2026, Keo Capital AB has a Sloan Ratio of -19.27%, indicating earnings are more likely to be made up of accruals.


Keo Capital AB  (STU:7M7) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Jun. 2026, Keo Capital AB has a Sloan Ratio of -19.27%, indicating earnings are more likely to be made up of accruals.


Keo Capital AB Sloan Ratio % Related Terms


Keo Capital AB Sloan Ratio % Historical Data

* Premium members only.

The historical data trend for Keo Capital AB's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Keo Capital AB Sloan Ratio % Chart

Keo Capital AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.35 14.18 -56.43 7.87 -47.24

Keo Capital AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -53.67 -53.18 -54.11 -35.21 -19.27

STU:7M7 vs CRM, SHOP, UBER: Sloan Ratio % Comparison

For the Software - Application subindustry, Keo Capital AB's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Keo Capital AB Sloan Ratio % vs Software Industry

For the Software industry and Technology sector, Keo Capital AB's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Keo Capital AB's Sloan Ratio % falls into.


STU:7M7
35GF Score
Keo Capital AB STU:7M7
Sloan Ratio % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Keo Capital AB Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Keo Capital AB's Sloan Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2025 )-Cash Flow from Operations (A: Dec. 2025 )
-Cash Flow from Investing (A: Dec. 2025 ))/Total Assets (A: Dec. 2025 )
=(-21.133--3.207
-28.665)/98.63
=-47.24%

Keo Capital AB's Sloan Ratio for the quarter that ended in Jun. 2026 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Jun. 2026 )
=(-51.441--19.259
-21.496)/278.623
=-19.27%

Keo Capital AB's Net Income for the trailing twelve months (TTM) ended in Jun. 2026 was -4.944 (Sep. 2025 ) + -4.05 (Dec. 2025 ) + -0.709 (Mar. 2026 ) + -41.738 (Jun. 2026 ) = €-51.44 Mil.
Keo Capital AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was -1.471 (Sep. 2025 ) + -3.522 (Dec. 2025 ) + -1.892 (Mar. 2026 ) + -12.374 (Jun. 2026 ) = €-19.26 Mil.
Keo Capital AB's Cash Flow from Investing for the trailing twelve months (TTM) ended in Jun. 2026 was 48.138 (Sep. 2025 ) + -13.871 (Dec. 2025 ) + -10.822 (Mar. 2026 ) + -1.949 (Jun. 2026 ) = €21.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Sloan Ratio % →
What does a Sloan Ratio % of -19.27% mean?
Keo Capital AB (STU:7M7) has a Sloan Ratio % of -19.27% as of Jun. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Keo Capital AB and its competitors.
Is Keo Capital AB's Sloan Ratio % too high?
Keo Capital AB's current Sloan Ratio % is -19.27%. Overall, Keo Capital AB has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Keo Capital AB's Sloan Ratio % compare to CRM and SHOP?
Keo Capital AB's Sloan Ratio % of -19.27% can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Software company?
A good Sloan Ratio % depends on the Software industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Keo Capital AB and its competitors. Keo Capital AB's current Sloan Ratio % is -19.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Keo Capital AB stock overvalued right now?
Based on GuruFocus' analysis, Keo Capital AB (STU:7M7) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.21, compared to a current price of €0.72 — trading 243.8% above its estimated fair value. The current Sloan Ratio % is -19.27%. Keo Capital AB's overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Keo Capital AB (STU:7M7), the current Sloan Ratio % is -19.27% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Keo Capital AB (STU:7M7) Overvalued in 2026?

Based on GuruFocus' analysis, Keo Capital AB stock appears to be overvalued. The current stock price of €0.72 is trading 243.8% above its estimated GF Value™ of €0.21. GuruFocus considers Keo Capital AB to be Significantly Overvalued.

Key valuation signals for STU:7M7:

  • Sloan Ratio %: -19.27%
  • GF Value™: €0.21 vs. price of €0.72 (243.8% above fair value)
  • GF Score™: 35/100 with 3 warning signs

No single metric tells the full story. See the STU:7M7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Keo Capital AB Business Description

Address Eriksbergsgatan 10, Stockholm, SWE, 114 30
Maha Capital AB is a Swedish company operating in the oil and gas industry. It focuses on acquiring and developing profitable oil and gas assets globally, to build a diversified and balanced portfolio in the energy, oil & gas, and minerals sectors. Its portfolio includes the financial investment in Brava Energia, the publicly traded Brazilian oil and gas company, the operated oil producing fields in the Illinois Basin, and its investments in the PetroUrdaneta project in Venezuela. The company's operating segments include the United States of America (USA) and Corporate. A majority of its revenue is generated from the United States of America, which includes all oil and gas activities in the Illinois Basin. The company derives revenue from the sale of oil and gas produced in the USA.
35GF Score

Get the complete analysis for STU:7M7

Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.72
Price
€0.21
GF Value